Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Paratek
Paratek
Activist investor NexPoint threatens to block Paratek's $462M sale
Fierce Pharma
Wed, 06/28/23 - 10:31 pm
Paratek
Novo Holdings
NexPoint
activist investors
Biotech M&A is picking back up - here are the latest deals
BioPharma Dive
Tue, 06/13/23 - 11:37 am
Novartis
Chinook Therapeutics
Paratek
Sobi
CTI BioPharma
Astellas
Iveric Bio
Assertio Holdings
Spectrum Pharmaceuticals
Merck
Prometheus Biosciences
Pfizer
Seagen
Sanofi
Provention Bio
Sun Pharma
Concert Pharmaceuticals
BioNTech
InstaDeep
AstraXeneca
CinCor Pharma
Ipsen
Albireo
Chiesi
Amryt
Moderna Therapeutics
OriCiro Genomics
Antibiotic maker Paratek, low on cash, agrees to a buyout
BioPharma Dive
Tue, 06/6/23 - 04:17 pm
Paratek
antibiotics
M&A
Novo Nordisk Foundation
As U.S. calls for stateside manufacturing, antibiotic maker Paratek gambles on 'onshoring' effort
Fierce Pharma
Mon, 06/8/20 - 10:32 am
drug manufacturing
Paratek
pandemic
COVID-19
antibiotics
Paratek wins US contract to develop anthrax treatment
BioPharma Dive
Fri, 12/20/19 - 10:15 am
Paratek
government contracts
anthrax
Nuzyra
Paratek's top antibiotic fails to clear a key competitive hurdle in head-to-head studies
Endpoints
Fri, 11/1/19 - 10:28 am
Nuzyra
UTIs
Paratek
Paratek caps 20-year R&D journey with FDA OK for its broad spectrum antibiotic — time to talk launch
Endpoints
Wed, 10/3/18 - 09:49 am
antibiotics
FDA
R&D
Paratek
Nuzyra
Paratek clears one last big hurdle on the way to an FDA marketing decision for antibiotic
Endpoints
Wed, 08/8/18 - 08:11 pm
Paratek
antibiotics
omadacycline
FDA
advisory panels
Paratek antibiotic not inferior to current treatments: FDA staff
Reuters
Tue, 08/7/18 - 12:05 am
Paratek
antibiotics
FDA
aminomethylcyclines
The Week Ahead In Biotech: Conferences, PDUFA Dates And IPOs
Yahoo/Benzinga
Sun, 08/5/18 - 07:25 pm
biotech
IPOs
Pain Therapeutics
Remoxy
Vertex Pharmaceuticals
lumacaftor/ivacaftor
Alnylam
Patisiran
Regeneron
Eylea
Insmed
Paratek
Vaccinex
After 20 years, Paratek’s broad-spectrum antibiotic is headed to the FDA
Drug Delivery Business News
Thu, 02/15/18 - 10:57 am
Paratek
antibiotics
broad spectrum antibiotics
FDA
omadacycline
New antibiotic therapies: what future?
GoinPharma
Mon, 10/23/17 - 10:00 pm
antibiotics
Merck
Paratek
Tetraphase Pharmaceuticals
Motif Biosciences
The Medicines Company
Paratek goes 3-for-3 in PhIII, but antibiotic stumbles on side effect profile
Endpoints
Tue, 07/18/17 - 09:21 am
Paratek
antibiotics
clinical trials
side effects
omadacycline
Biotech Movers: Sarepta, Paratek, PDL BioPharma
TheStreet.com
Mon, 04/24/17 - 10:14 am
Sarepta Therapeutics
Exondys 5
Paratek
omadacycline
PDL Biopharma
patents
Merck
Keytruda
Paratek Pharma shares surge 30% after antibiotic study results
Marketwatch
Tue, 04/4/17 - 12:22 am
Paratek
antibiotics
moxifloxacin
Allergan, Paratek Pharma report positive results in late-stage trial of acne treatment
Marketwatch
Mon, 03/27/17 - 10:57 am
Allergan
Paratek
acne
sarecycline
Paratek Makes Milestone Movement in Late-Stage Trial
24/7 Wall St
Fri, 06/17/16 - 12:12 pm
Paratek
clinical trials
omadacycline
antibiotics
skin infections
9 Biotech Picks for 2016
Barron's
Sat, 01/2/16 - 10:19 am
biotech
Adaptimmune
Dermira
FibroGen
Incyte
Intra-Cellular Therapies
Seres Therapeutics
Ophthotech
Neurocrine Biosciences
Paratek
How Paratek hopes to succeed in antibiotics despite Tetraphase’s fail
Bizjournals.com
Wed, 10/14/15 - 09:17 am
Paratek
Tetraphase
antibiotics
omadacycline
FDA
Pharma Stocks To Keep An Eye On: Pozen Inc. (POZN), Paratek Pharmaceuticals (PRTK), Oncothyreon Inc. (ONTY), Tetraphase Pharmaceuticals (TTPH)
Bidness Etc.
Thu, 12/18/14 - 10:07 am
Pozen
Tetraphase Pharmaceuticals
Paratek
Oncothyreon
Pages
1
2
next ›
last »